Skin and soft tissue infections: Classification and epidemiology;Infezioni della cute e dei tessuti molli: Classificazione ed epidemiologia

Infezioni in Medicina

Volumn 17, Issue SUPPL. 4, 2009, Pages 6-17

  Esposito, Silvano ^a   Leone, Sebastiano ^a   Petta, Ester ^a   Noviello, Silvana ^a   Iori, Ido ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Azienda Ospedaliera ASMN di Reggio Emilia   (Italy)

Author keywords

Classification; Epidemiology; Skin and soft tissue infections

Indexed keywords

ANTIMICROBIAL THERAPY; CLINICAL FEATURE; DISEASE SEVERITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NEOPLASM; ORGAN TRANSPLANTATION; POPULATION RESEARCH; PREVALENCE; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION;

ALGORITHMS; CASE MANAGEMENT; COMORBIDITY; DRUG RESISTANCE, MICROBIAL; FASCIITIS, NECROTIZING; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; SEPSIS; SEVERITY OF ILLNESS INDEX; SKIN DISEASES, INFECTIOUS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; WOUND INFECTION;

EID: 77951567121     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Ki V., Rotstein C. Bacterial skin and soft tissue infections in adults: a review of their epidemiology, pathogenesis, diagnosis,treatment and site of care. Can. J. Infect. Dis. Med. Microbiol. 19, 173-184, 2008. (Pubitemid 351754184)
2. Eron L.J., Lipsky B.A., Low D E., et al. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J. Antimicrob. Chemother. 52 (Suppl. 1), 3-17, 2003.
3. Tice A.D., Rehm S.J., Dalovisio J.R., et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin. Infect. Dis. 38, 1651-1672, 2004.
4. Esposito S., Leone S., Noviello S., et al. Outpatient parenteral antibiotic therapy for bone and joint infections: an italian multicenter study. J. Chemother. 19, 417-422, 2007.
5. Esposito S., Ianniello F., Noviello S. Outpatient Parenteral Antibiotic Therapy (OPAT): the Italian Registry. Infez. Med. 3, 169-175, 2002.
6. Esposito S., Noviello S., Leone S., et al. Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Int. J. Antimicrob. Agents. 24, 473-478, 2004. (Pubitemid 39425160)
7. Di Nubile M.J., Lipsky B.A. Complicated infections of the skin and skin structures: when the infection is more than skin deep. J. Antimicrob. Chemother. 53 (Suppl. 2), 37-50, 2004.
8. Stevens D.L., Bisno A.L., Chambers H.F., et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin. Infect. Dis. 41, 1373-1406, 2005
9. May A.K., Skin and soft tissue infections. Surg. Clin. N. Am. 89, 403-420, 2009.
10. Nathwani D. New antibiotics for the management of complicated skin and soft tissue infections: are they any better? Int. J. Antimicrob. Agents. 33 (Suppl. 3), 24-29, 2009.
11. Guidance for Industry: Uncomplicated and complicated skin and skin structure infections: developing antimicrobial drugs treatment. US Dept of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 1998. Available at: http://www.fda.gov/CDER/guidance/ 2566dft. pdf.
12. Merlino J., Malangoni M.A. Complicated skin and soft-tissue infections: Diagnostic approach and empiric treatment options. Clev. Clin. J. Med. 74 (Suppl. 4), 21-28, 2007.
13. Elston D.M. Optimal antibacterial treatment of uncomplicated skin and skin structure infections: Applying a novel treatment algorithm. J. Drugs Dermatol. 4 (Suppl. 6), 15-19, 2005.
14. Esposito S., Noviello S., Leone S. Skin and soft tissue infections: current therapeutic options. Infez. Med. 2, 65-73, 2008. (Pubitemid 351976634)
15. Herold B.C, Immergluck L.C, Maranan L.C, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279, 593-598, 1998.
16. Tristan A., Bes M., Meugnier H., et al. Global distribution of Panton-Valentin leukocidin-positive methicillin-resistant Staphylococcus aureus. Emerg. Infect Dis. 13, 594-600, 2007.
17. CDC. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants - Colorado, Indiana, Pennsylvania, and Los Angeles Country, 2000-2003. MMWR. 52, 793-795, 2003.
18. Kazakova Sv, Hageman Jc, Matava M, et al. A Clone of methicillin- Resistant Staphylococcus aureus among professional football players. N. Engl. J. Med. 352, 468-475, 2005.
19. Zinderman C.E., Conner B., Malakooti M.A, Lamar J.E., Armstrong A., Bohnker B.K.. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg. Infect. Dis. 10, 941-944, 2004. (Pubitemid 38552772)
20. Naimi T.S., Ledell K.H, Como-Sabetti K., et al. Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 290, 2976-2986, 2003.
21. Moet G.J., Jones R.N., Biedenbach D.J., Stilwell M.G., Fritsche T.R. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY antimicrobial surveillance program (1998-2004). Diagn. Microbiol. Infect. Dis. 57, 7-13, 2007.
22. Stulberg D.L., Penrod M.A., Blatny R.A. Common Bacterial Skin Infections Am. Fam. Phys. 1, 66, 119-124, 2002.
23. Centers for Disease Control. Incidence of soft tissue infections: San Francisco General Hospital. 1996-2000. MMWR. 50, 381-384, 2001.
24. Orientamenti terapeutici per il trattamento delle infezioni della cute e dei tessuti molli in Medicina Interna. Gruppo Multidisciplinare FADOI. GIMI 4 (Suppl. 3), 1-79, 2005.
25. Vinh D.C., Embil J.M. Severe skin and soft tissue infections and associated critical illness. Curr. Infect. Dis. Rep. 8, 375-383, 2006. (Pubitemid 44445711)
26. Vinh D.C., Embil J.M. Rapidly progressive soft tissue infections. Lancet Infect. Dis. 5, 501-513, 2005. (Pubitemid 41022026)
27. Baddour LM. Epidemiology, clinical features, and diagnosis of cellulitis. 〈http://www.utdol.com/utd/content/topic.do?topicKey=skin.inf/ 11185&selectedTitle=1150&source=searc-result2008
28. Ellis Simonsen S.M., van Orman E.R., Hatch B.E., et al. Cellulitis incidence in a defined population. Epidemiol. Infect. 134, 293-299, 2006.
29. Gabillot-Carré M., Roujeau J.C. Acute bacterial skin infections and cellulitis. Curr. Opin. Infect. Dis. 20, 118-123, 2007. (Pubitemid 46340792)
30. McNamara D.R., Tleyjeh I.M., Berbari E.F., et al. Incidence of lower-extremity cellulitis: a population-based study in Olmsted County, Minnesota. Mayo Clin. Proc. 82, 817-821, 2007. (Pubitemid 47015460)
31. Pallin D.J., Egan D.J., Pelletier A.J., Espinola J.A., Hooper D.C., Camargo C.A. Jr. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann. Emerg. Med. 51, 291-298, 2008.
32. Sarani B., Strong M., Pascual J., Schwab W. Necrotizing fasciitis: current concepts and review of the literature. J. Am. Coll. Surg. 208, 2, 279-288, 2009.
33. Cainzos M., Gonzalez-Rodriguez F.J. Necrotizing soft tissue infections. Curr. Opin. Crit. Care. 13, 433-439, 2007.
34. Anaya D, McMahon K, Nathens A. Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch. Surg. 140, 151-157, 2005. (Pubitemid 40229103)
35. Kihiczak G.G., Schwartz R.A., Kapila R. Necrotizing fasciitis: a deadly infection. J. Eur. Acad. Dermatol. Venereol. 20, 365-369, 2006.
36. Louis M.L., Launay F., Guillaume J.M. Necrotizing cellulitis complicating varicella in two children given non steroidal anti-inflammatory drugs. Rev. Chir. Orthop. Reparatrice Appar. Mot. 92, 504-507, 2006.
37. Liu S.Y., Ng S.S., Lee J.F. Multilimb necrotizing fasciitis in a patient with rectal cancer. World J. Gastroenterol. 12, 5256-5258, 2006.
38. Marron C.D., McArdle G.T., Rao M. Perforated carcinoma of the caecum presenting as necrotising fasciitis of the abdominal wall, the key to early diagnosis and management. BMC Surg. 29, 6-11, 2006.
39. Tsai Y.H., Hsu R.W., Huang T.J. Necrotizing soft tissue infections and sepsis caused by Vibrio vulnificus compared with those caused by Aeromonas species. J. Bone Joint Surg. Am. 89, 631-636, 2007.
40. Spock C.R., Miki R.A., Shah R.V., Grauer J.N. Necrotizing infection of the spine. Spine. 31, 342-344, 2006.
41. Nichols R.L., Sander F. Clinical Presentations of Soft-Tissue Infections and Surgical Site Infections Clin. Infect. Dis. 33 (Suppl. 2), 84-93, 2001.
42. Owens C.D., Stoessel K. Surgical site infections: epidemiology, microbiology and prevention J. Hosp. Infect. 70, 2, 3-10, 2008.
43. Anderson D.J., Kaye K.S., Staphylococcal surgical site infections Infect. Dis. Clin. N. Am. 23, 53-72, 2009.
44. Boni L., Benevento A., Rovera F, et al. Infective complications in laparoscopic surgery. Surg. Infect. (Larchmt) 7 (Suppl 2), 109-111, 2006.
45. Kirkland K.B., Briggs J.P., Trivette S.L., Wilkinson W.E., Sexton D.J. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect. Control Hosp. Epidemiol. 20, 725-730, 1999.
46. Di Piro J.T., Martindale R.G., Bakst A., Vacani P.F., Watson P., Miller M.T. Infection in surgical patients: effects on mortality, hospitalization, and post-discharge care. Am. J. Health Syst. Pharm. 55, 777-781, 1998.
47. Whitehouse J.D., Friedman N.D., Kirkland K.B., Richardson W.J., Sexton D.J. The impact of surgical-site infections following orthopaedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect. Control Hosp. Epidemiol. 23, 4, 183-189, 2002.
48. Hollenbeak C.S., Murphy D., Dunagan W.C., Fraser V.J. Nonrandom selection and the attributable cost of surgical-site infections. Infect. Control Hosp. Epidemiol. 23, 4, 177-182, 2002. (Pubitemid 34297270)
49. De Werra C., Surgical infections in Italy, Infez. Med. 17, 4, 2009 (in press).
50. Diekema D.J., BootsMiller B.J., Vaughn T.E., et al. Antimicrobial resistance trends and outbreak frequency in United States Hospitals. Clin. Infect. Dis. 38, 78-85, 2004.
51. Engemann J.J., Carmeli Y., Cosgrove S.E., et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin. Infect. Dis. 36, 592-598, 2003.
52. Stryjewski M.E., Chambers H.F.. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 46 (Suppl. 5), 368-377, 2008.
53. Klein E., Smith D.L., Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg. Infect. Dis. 13, 1840-1846, 2007.
54. Frazee B.W., Lynn J., Charlebois E.D., Lambert L., Lowery D., Perdreau-Remington F. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann. Emerg. Med. 45, 311-320, 2005. (Pubitemid 40261163)
55. Szumowski J.D., Cohen D.E., Kanaya F., Mayer K.H. Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic. Antimicrob. Agents Chemother. 51, 423-428, 2007. (Pubitemid 46185256)